Monodox

DRUG3 trials

Sponsors

Par Pharmaceutical, Inc.

Conditions

To Determine Bioequivalence Under Fasting ConditionsTo Determine Bioequivalence Under Fed Conditions

Phase 1

Bioequivalence Study Doxycycline Tablets and Monodox Capsules Under Fasting Conditions

CompletedNCT00652795

Par Pharmaceutical, Inc.To Determine Bioequivalence Under Fasting Conditions

Start: 2004-07-31End: 2004-09-30Updated: 2008-04-04

Bioavailability Study of Doxycycline Monohydrate Capsules and Monodox Under Fasting Conditions

CompletedNCT00653380

Par Pharmaceutical, Inc.To Determine Bioequivalence Under Fasting Conditions

Start: 1999-09-30End: 1999-10-31Updated: 2008-04-04

Bioavailability Study of Doxycycline Monohydrate Capsules and Monodox Under Fasting and Fed Conditions

CompletedNCT00652704

Par Pharmaceutical, Inc.To Determine Bioequivalence Under Fed Conditions

Start: 1999-07-31End: 1999-09-30Updated: 2017-09-26